A rating of 29 puts Immuneering Corp (IMRX) near the bottom of the Biotechnology industry according to InvestorsObserver. Immuneering Corp's score of 29 means it scores higher than 29% of stocks in the industry. Immuneering Corp also received an overall rating of 39, putting it above 39% of all stocks. Biotechnology is ranked 18 out of the 148 industries.
IMRX has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on IMRX!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 39 means the stock is more attractive than 39 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Immuneering Corp Stock Today?
Immuneering Corp (IMRX) stock is trading at $2.90 as of 9:38 AM on Monday, Apr 1, a gain of $0.01, or 0.35% from the previous closing price of $2.89. The stock has traded between $2.80 and $2.96 so far today. Volume today is low. So far 41,543 shares have traded compared to average volume of 1,127,652 shares.
Click Here to get the full Stock Report for Immuneering Corp stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
